Jacobs Levy Equity Management Inc. Takes $1.05 Million Position in Orthofix Medical Inc. $OFIX

Jacobs Levy Equity Management Inc. purchased a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX) during the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 64,230 shares of the medical device company’s stock, valued at approximately $1,048,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Orthofix Medical by 4.5% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,348 shares of the medical device company’s stock valued at $338,000 after acquiring an additional 836 shares during the last quarter. Gamco Investors INC. ET AL boosted its position in shares of Orthofix Medical by 1.0% during the 1st quarter. Gamco Investors INC. ET AL now owns 157,100 shares of the medical device company’s stock valued at $2,562,000 after acquiring an additional 1,500 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Orthofix Medical by 5.9% during the 4th quarter. BNP Paribas Financial Markets now owns 36,798 shares of the medical device company’s stock valued at $642,000 after acquiring an additional 2,040 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of Orthofix Medical during the 4th quarter valued at about $45,000. Finally, Graham Capital Management L.P. boosted its position in shares of Orthofix Medical by 25.2% during the 4th quarter. Graham Capital Management L.P. now owns 15,510 shares of the medical device company’s stock valued at $271,000 after acquiring an additional 3,124 shares during the last quarter. Institutional investors and hedge funds own 89.76% of the company’s stock.

Orthofix Medical Stock Up 5.3%

Shares of NASDAQ:OFIX opened at $15.00 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.50. The firm has a market capitalization of $592.35 million, a PE ratio of -4.73 and a beta of 0.86. The firm’s 50-day moving average is $12.83 and its two-hundred day moving average is $13.28. Orthofix Medical Inc. has a 1 year low of $10.24 and a 1 year high of $20.73.

Orthofix Medical (NASDAQ:OFIX) last issued its quarterly earnings results on Tuesday, August 5th. The medical device company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.40). The business had revenue of $203.12 million for the quarter, compared to analysts’ expectations of $196.89 million. Orthofix Medical had a negative return on equity of 25.43% and a negative net margin of 15.29%. Orthofix Medical has set its FY 2025 guidance at EPS. Analysts predict that Orthofix Medical Inc. will post -2.81 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on OFIX shares. JMP Securities reissued a “market perform” rating on shares of Orthofix Medical in a research report on Friday, June 6th. Wall Street Zen raised shares of Orthofix Medical from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. Finally, Barrington Research upgraded shares of Orthofix Medical to a “strong-buy” rating and set a $16.00 price objective on the stock in a report on Monday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $21.50.

Insider Transactions at Orthofix Medical

In other Orthofix Medical news, insider Aviva Mcpherron sold 3,728 shares of the business’s stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total transaction of $39,181.28. Following the sale, the insider directly owned 46,322 shares in the company, valued at $486,844.22. This represents a 7.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by company insiders.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.